Anti-angiogenic agents
- 1 August 2000
- journal article
- review article
- Published by Elsevier in European Journal Of Cancer
- Vol. 36 (13) , 1713-1724
- https://doi.org/10.1016/s0959-8049(00)00149-0
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- Continuous low-dose therapy with vinblastine and VEGF receptor-2 antibody induces sustained tumor regression without overt toxicityJournal of Clinical Investigation, 2000
- Incipient AngiogenesisJNCI Journal of the National Cancer Institute, 2000
- Measurement of clinical and subclinical tumour response using [18F]-fluorodeoxyglucose and positron emission tomography: review and 1999 EORTC recommendationsEuropean Journal Of Cancer, 1999
- Antitumor Activity of Thalidomide in Refractory Multiple MyelomaNew England Journal of Medicine, 1999
- Æ-941, an inhibitor of angiogenesis: rationale for development in combination with induction chemotherapy/radiotherapy in patients with non-small-cell lung cancer (nsclc)European Journal Of Cancer, 1999
- Anti-angiogenesis drugsEuropean Journal Of Cancer, 1999
- Vascular Channel Formation by Human Melanoma Cells in Vivo and in Vitro: Vasculogenic MimicryThe American Journal of Pathology, 1999
- Angiogenesis in primary lung cancer and lung secondariesEuropean Journal Of Cancer, 1996
- Successful Treatment of an Angiogenic DiseaseNew England Journal of Medicine, 1989
- Tumor Angiogenesis: Therapeutic ImplicationsNew England Journal of Medicine, 1971